Marco Sella

Marco Sella is an experienced clinical operations consultant currently working at Genespire since April 2025. Sella has held various roles in the pharmaceutical industry, including Titolare at Farmacia Sella since January 2018, and a consultant senior clinical trial manager at IO Biotech until October 2025. Previous experience includes consulting as a clinical site manager at Bellicum Pharmaceuticals, project management at Precision For Medicine, and trial operations management at Novartis. Sella's earlier career includes positions at ICON plc as a CRA II and at CABYC, S.L. as a CRA, where responsibilities involved site initiation, monitoring, and regulatory compliance. Sella began in the pharmaceutical field as a pharmacist manager and a data analyst at IMS Health. Educational qualifications include a degree in Pharmaceutical Chemistry from Alma Mater Studiorum – Università di Bologna.